...
首页> 外文期刊>AIDS Research and Human Retroviruses >Structural basis of drug resistance by genetic variants of HIV type 1 clade c protease from India.
【24h】

Structural basis of drug resistance by genetic variants of HIV type 1 clade c protease from India.

机译:来自印度的HIV 1型进化枝c蛋白酶的遗传变异产生的耐药性的结构基础。

获取原文
获取原文并翻译 | 示例

摘要

Using computer modeling of three-dimensional structures and structural information available on the crystal structures of HIV-1 protease, we investigated the structural effects of mutations, in treatment-naive and treatment-exposed individuals from India and postulated mechanisms of resistance in clade C variants. A large number of models (14) have been generated by computational mutation of the available crystal structures of drug bound proteases. Localized energy minimization was carried out in and around the sites of mutation in order to optimize the geometry of interactions present. Most of the mutations result in structural differences at the flap that favors the semiopen state of the enzyme. Some of the mutations were also found to confer resistance by affecting the geometry of the active site. The E35D mutation affects the flap structure in clade B strains and E35N and E35K mutation, seen in our modeled strains, have a more profound effect. Common polymorphisms at positions 36 and 63 in clade C also affected flap structure. Apart from a few other residues Gln-58, Asn-83, Asn-88, and Gln-92 and their interactions are important for the transition from the closed to the open state. Development of protease inhibitors by structure-based design requires investigation of mechanisms operative for clade C to improve the efficacy of therapy.
机译:使用三维结构的计算机建模和关于HIV-1蛋白酶晶体结构的结构信息,我们调查了印度未经治疗和接触过治疗的个体中突变的结构效应以及进化枝C变体的假定抗性机制。通过对药物结合的蛋白酶的可用晶体结构进行计算突变,已经生成了许多模型(14)。为了优化存在的相互作用的几何结构,在突变位点及其周围进行了局部能量最小化。大多数突变导致在襟翼处的结构差异,有利于酶的半开放状态。还发现一些突变通过影响活性位点的几何结构而赋予抗性。 E35D突变影响进化枝B菌株的皮瓣结构,在我们的模拟菌株中看到的E35N和E35K突变具有更深远的影响。进化枝C中36和63位的常见多态性也影响襟翼结构。除了一些其他残基,Gln-58,Asn-83,Asn-88和Gln-92以及它们的相互作用对于从封闭状态向开放状态的过渡也很重要。通过基于结构的设计开发蛋白酶抑制剂需要研究进化枝C的有效机制,以提高治疗效果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号